Florida Attorney General Ashley Moody urged congressional leadership to pass the Combating Illicit Xylazine Act (H.R.1839/S.993).
This bill would provide critical measures to combat the widespread illicit use and trafficking of xylazine and help prevent xylazine-related deaths.
Moody’s call on Congress follows a surge in overdose deaths nationwide related to xylazine, a potent veterinary medication that is being widely mixed with illicit drugs, such as fentanyl, and is easily obtainable online.
In the news: Georgia Man Sentenced In ‘Laundry Detergent’ Meth Distribution In The Tampa Bay Area
Over the past few months, multiple federal agencies, including the U.S. Drug Enforcement Administration, have issued public alerts about the dangers of xylazine.
“Xylazine burst onto the illicit substances scene this year exacerbating the worst overdose crisis we have ever seen. This flesh-eating zombie drug is being combined with extremely deadly fentanyl and for months we have been fighting to educate the public about its dangers. I urge all members of Congress to support the important Combatting Illicit Xylazine Act,” said Moody.
Xylazine is only approved by the U.S. Food and Drug Administration as a veterinary medicine used to sedate and relieve pain in large animals. In humans, xylazine is known to depress breathing and heart rate, lower blood pressure, and cause unconsciousness, necrosis and even death. Xylazine is not an opioid; thus, existing medications like naloxone are not effective in reversing the drug’s effects even if used with opioids.
In the news: Florida Man Sentenced To Life In Prison For Sexually Exploiting A Child On Social Media
According to DEA, a dramatic increase in xylazine-related overdose deaths across the U.S. occurred between 2020 and 2021, with an increase of 1,127% in the Southern region, 750% in the Western region, 516% in the Mideast region and 103% in the Northeast region. Additionally, in 2022, approximately 23% of fentanyl powder and 7% of fentanyl pills seized by the DEA contained xylazine.
In a letter to congressional leaders today, Attorney General Moody urged lawmakers to pass the Combating Illicit Xylazine Act. The bill federally schedules the dangerous drug and allows DEA to track manufacturing and sales of xylazine to ensure it is not diverted, among other measures.
Android Users, Click To Download The Free Press App And Never Miss A Story. Follow Us On Facebook and Twitter. Signup for our free newsletter.
We can’t do this without your help; visit our GiveSendGo page and donate any dollar amount; every penny helps.